Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980–2000
The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Mortality from coronary heart disease in the United States has decreased substantially in recent decades. We conducted a study to determine how much of this decrease could be explained by the use of medical and surgical treatments as opposed to changes in cardiovascular risk factors. METHODS: We applied a previously validated statistical model, IMPACT, to data on the use and effectiveness of specific cardiac treatments and on changes in risk factors between 1980 and 2000 among U.S. adults 25 to 84 years old. The difference between the observed and expected number of deaths from coronary heart disease in 2000 was distributed among the treatments and risk factors included in the analyses. RESULTS: From 1980 through 2000, the age-adjusted death rate for coronary heart disease fell from 542.9 to 266.8 deaths per 100,000 population among men and from 263.3 to 134.4 deaths per 100,000 population among women, resulting in 341,745 fewer deaths from coronary heart disease in 2000. Approximately 47% of this decrease was attributed to treatments, including secondary preventive therapies after myocardial infarction or revascularization (11%), initial treatments for acute myocardial infarction or unstable angina (10%), treatments for heart failure (9%), revascularization for chronic angina (5%), and other therapies (12%). Approximately 44% was attributed to changes in risk factors, including reductions in total cholesterol (24%), systolic blood pressure (20%), smoking prevalence (12%), and physical inactivity (5%), although these reductions were partially offset by increases in the body-mass index and the prevalence of diabetes, which accounted for an increased number of deaths (8% and 10%, respectively). CONCLUSIONS: Approximately half the decline in U.S. deaths from coronary heart disease from 1980 through 2000 may be attributable to reductions in major risk factors and approximately half to evidence-based medical therapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Between 1950 and 1970 most of the decline in mortality rates from CVD was due to prevention (Goldman & Cook, 1984), whereas acute disease management and medical treatments accounted for about half of the decline between 1980 and 2000 (Ford et al., 2007).”
From Mortality and Morbidity Trends: Is There Compression of Morbidity? (2011) · cites this paper as Ford et al., 2007
In the citing paper
“Past studies show the effect of access to high-quality personal health care on both communicable and non-communicable diseases, highlighting the importance of prioritising personal health-care access and quality for all populations across the development spectrum.39–42”
In the citing paper
“Prevention works: .50% of the reductions seen in CHD mortality relate to changes in risk factors, and 40% to improved treatments.”
From European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) (2012) · cites this paper as [29]
In the citing paper
“Another approach to understanding the changes in CVD mortality and incidence rates is by applying models such as the IMPACT mortality model.29 Based on information on changes in coronary risk factors and in treatment as obtained from the results of RCTs regarding the effectiveness of different treatment modalities, it estimates the expected influence on CHD mortality by age and gender.”
From European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) (2012) · cites this paper as [29]
In the citing paper
“Beneficial reductions in major risk factors-in particular smoking, BP, and cholesterol-accounted for more than half of the decrease in CHD deaths, although they were counteracted by an increase in the prevalence of obesity and type 2 diabetes; 40% of the decline in CHD death rates is attributed to better treatments of acute myocardial infarction, heart failure, and other cardiac conditions.”
From European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) (2012) · cites this paper as [29]
9 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Collaboration, A. T. (2002) · BMJ · doi:10.1136/bmj.324.7329.71 · Cited by 6,943
Prevalence of Overweight and Obesity Among US Children, Adolescents, and Adults, 1999-2002
Hedley, A. A. (2004) · JAMA · doi:10.1001/jama.291.23.2847 · Cited by 4,460
Writing Group Members, Thom, T., Haase, N., Rosamond, W., Howard, V. J., Rumsfeld, J., Manolio, T., Zheng, Z.-J., Flegal, K., O’Donnell, C., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.171600 · Cited by 3,451
Rosamond, W., Flegal, K., Friday, G., Furie, K., Go, A., Greenlund, K., Haase, N., Ho, M., Howard, V., Kissela, B., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.179918 · Cited by 3,277
Excess Deaths Associated With Underweight, Overweight, and Obesity
Flegal, K. M. (2005) · JAMA · doi:10.1001/jama.293.15.1861 · Cited by 2,824
Harris, M. I., Flegal, K. M., Cowie, C. C., Eberhardt, M. S., Goldstein, D. E., Little, R. R., Wiedmeyer, H.-M., & Byrd-Holt, D. D. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.518 · Cited by 2,703
A Potential Decline in Life Expectancy in the United States in the 21st Century
Olshansky, S. J., Passaro, D. J., Hershow, R. C., Layden, J., Carnes, B. A., Brody, J., Hayflick, L., Butler, R. N., Allison, D. B., & Ludwig, D. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmsr043743 · Cited by 2,612
Hajjar, I. (2003) · JAMA · doi:10.1001/jama.290.2.199 · Cited by 2,409
A Potential Decline in Life Expectancy in the United States in the 21st Century
Olshansky, S. J., Passaro, D. J., Hershow, R. C., Layden, J., Carnes, B. A., Brody, J., Hayflick, L., Butler, R. N., Allison, D. B., & Ludwig, D. S. (2005) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000167407.83915.e7 · Cited by 1,944
Research works printed but not linked: 3
- 2004, MMWR Morb Mortal Wkly Rep, 53, 82
- Ryan R, 2001, Health Stat Q, 12, 34
- Mokdad AH, 2003, MMWR Recomm Rep, 52, 1
Cited by
Items 801–900 of 1,006
Carolina Nazzal, N., Pabla Campos, T., Ramón Corbalán, H., Lanas, F. T., Jorge Bartolucci, J., Patricio Sanhueza, C., Cavada, G., & Juan Carlos Prieto, D. (2008) · Revista médica de Chile · doi:10.4067/s0034-98872008001000001 · Cited by 51
Rehn, T. A., Winett, R. A., Wisløff, U., & Rognmo, Ø. (2013) · The Open Cardiovascular Medicine Journal · doi:10.2174/1874192401307010001 · Cited by 54
Cost-effectiveness analysis for imaging techniques with a focus on cardiovascular magnetic resonance
Francis, S. A., Daly, C., Heydari, B., Abbasi, S. A., Shah, R. V., & Kwong, R. Y. K. (2013) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/1532-429x-15-52 · Cited by 38
Is Disability Obesity's Price of Longevity?
Gregg, E. W., & Guralnik, J. M. (2007) · JAMA · doi:10.1001/jama.298.17.2066 · Cited by 40
Novel approaches to antiplatelet therapy
Gresele, P., & Momi, S. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115297 · Cited by 36
A Modeling Study for Hip Fracture Rates in Romania
Moldovan, F., & Moldovan, L. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14093162 · Cited by 35
Modern Obesity Pharmacotherapy: Weighing Cardiovascular Risk and Benefit
Cunningham, J. W., & Wiviott, S. D. (2014) · Clinical Cardiology · doi:10.1002/clc.22304 · Cited by 37
Causes for the declining proportion of ventricular fibrillation in out-of-hospital cardiac arrest
Hulleman, M., Zijlstra, J. A., Beesems, S. G., Blom, M. T., van Hoeijen, D. A., Waalewijn, R. A., Tan, H. L., Tijssen, J. G. P., & Koster, R. W. (2015) · Resuscitation · doi:10.1016/j.resuscitation.2015.07.010 · Cited by 39
Trends in PCI Volume after Negative Results from the COURAGE Trial
Howard, D. H., & Shen, Y. (2013) · Health Services Research · doi:10.1111/1475-6773.12082 · Cited by 35
Park, G.-M., Yun, S., Cho, Y.-R., Gil, E. H., Sung, H.-H., Kim, S. H., Jo, M., Lee, M., Lee, S.-W., Kim, Y.-H., et al. (2015) · The International Journal of Cardiovascular Imaging · doi:10.1007/s10554-015-0587-0 · Cited by 37
Chase, J. D., Bogener, J. L., Ruppar, T. M., & Conn, V. S. (2015) · The Journal of Cardiovascular Nursing · doi:10.1097/jcn.0000000000000259 · Cited by 44
Jafar, T. H., de Silva, A., Naheed, A., Jehan, I., Liang, F., Assam, P. N., Legido‐Quigley, H., Finkelstein, E. A., Ebrahim, S. B. J., Wickremasinghe, R., et al. (2016) · Journal of Hypertension · doi:10.1097/hjh.0000000000001014 · Cited by 40
Wolfson, J., Vock, D. M., Bandyopadhyay, S., Kottke, T., Vazquez‐Benitez, G., Johnson, P., Adomavicius, G., & O'Connor, P. J. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.003670 · Cited by 33
Self-citationYankey, B. A., Rothenberg, R., Strasser, S. M., Ramsey-White, K., & Okosun, I. S. (2017) · European Journal of Preventive Cardiology · doi:10.1177/2047487317723212 · Cited by 48
RetractedTan, J., Choi, H. K., Xie, H. W., Sayre, E. C., Esdaile, J. M., & Aviña-Zubieta, J. A. (2018) · Arthritis Care & Research · doi:10.1002/acr.23587 · Cited by 35
Vuoti, A. O., Tulppo, M. P., Ukkola, O. H., Junttila, J. M., Huikuri, H. V., Kiviniemi, A. M., & Perkiömäki, J. S. (2021) · PLoS ONE · doi:10.1371/journal.pone.0254107 · Cited by 35
Ahmadi, M., & Lanphear, B. P. (2022) · BMC Public Health · doi:10.1186/s12889-021-12421-0 · Cited by 37
Impact of pre-admission depression on mortality following myocardial infarction
Sundbøll, J., Schmidt, M., Adelborg, K., Pedersen, L. H., Bøtker, H. E., Videbech, P., & Sørensen, H. T. (2017) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.116.194605 · Cited by 37
Cardiovascular Disease and Modifiable Cardiometabolic Risk Factors
Cannon, C. P. (2008) · Clinical cornerstone · doi:10.1016/s1098-3597(09)62037-8 · Cited by 41
Boden, W. E., Caterina, R. D., Kaski, J. C., Merz, C. N. B., Berry, C., Marzilli, M., Pepine, C. J., Barbato, E., Stefanini, G. G., Prescott, E., et al. (2024) · Circulation · doi:10.1161/circulationaha.123.065656 · Cited by 39
Enas, E. A., Kuruvila, A. T., Khanna, P., Pitchumoni, C. S., & Mohan, V. (2013) · PubMed Central · Cited by 48
Greenlund, K. J., Daviglus, M. L., & Croft, J. B. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e32832926fb · Cited by 36
Self-citationBriffa, T. G., Nedkoff, L., Peeters, A., Tonkin, A. M., Hung, J., Ridout, S. C., & Knuiman, M. W. (2011) · Heart · doi:10.1136/hrt.2010.210138 · Cited by 36
Modelling Coronary Heart Disease Mortality declines in the Republic of Ireland, 1985–2006
Kabir, Z., Perry, I. J., Critchley, J., O’Flaherty, M., Capewell, S., & Bennett, K. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.03.007 · Cited by 37
Self-citationThe inheritance of cardiovascular disease risk
Hanson, M. A. (2019) · Acta Paediatrica · doi:10.1111/apa.14813 · Cited by 36
Developing a Health Impact Model for Adult Lead Exposure and Cardiovascular Disease Mortality
Brown, L. L., Lynch, M. T., Belova, A., Klein, R., & Chiger, A. A. (2020) · Environmental Health Perspectives · doi:10.1289/ehp6552 · Cited by 35
Denham, A., Willis, M. D., Croft, D. P., Liu, L., & Hill, E. (2021) · Environmental Research · doi:10.1016/j.envres.2021.110872 · Cited by 35
Bjorck, L. M., Capewell, S., O’Flaherty, M., Lappas, G., Bennett, K., & Rosengren, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124769 · Cited by 36
Self-citationMichelsen, H. Ö., Sjölin, I., Bäck, M., García, M. G., Olsson, A., Sandberg, C., Șchiopu, A., & Leósdóttir, M. (2022) · Journal of Medical Internet Research · doi:10.2196/25224 · Cited by 39
Common Measures, Better Outcomes (COMBO)
Fernald, D. H., Froshaug, D. B., Dickinson, L. M., Balasubramanian, B. A., Dodoo, M. S., Holtrop, J. S., Hung, D. Y., Glasgow, R. E., Niebauer, L., & Green, L. A. (2008) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2008.08.006 · Cited by 34
Addressing cardiovascular inequalities among indigenous Australians
Brown, A. D. H. (2012) · Global Cardiology Science and Practice · doi:10.5339/gcsp.2012.2 · Cited by 43
Lifestyle Strategies for Cardiovascular Risk Reduction
Rippe, J. M., & Angelopoulos, T. J. (2014) · Current Atherosclerosis Reports · doi:10.1007/s11883-014-0444-y · Cited by 35
Primary and Secondary Prevention of Coronary Heart Disease
Gaziano, J. M., Ridker, P. M., & Libby, P. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0398-6.00049-4 · Cited by 34
Brancati, F. L., Evans, M., Furberg, C. D., Geller, N., Haffner, S., Kahn, S. E., Kaufmann, P. G., Lewis, C. E., Nathan, D. M., Pitt, B., et al. (2012) · Clinical Trials · doi:10.1177/1740774511432726 · Cited by 34
Decline in Incident Coronary Heart Disease
Luepker, R. V. (2008) · Circulation · doi:10.1161/circulationaha.107.747477 · Cited by 34
Smith, L. G., Herlitz, J. D., Karlsson, T., Berger, A. K., & Luepker, R. V. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht196 · Cited by 33
Acute Myocardial Infarction Mortality Before and After State-wide Smoking Bans
Rodu, B., Peiper, N. C., & Cole, P. T. (2011) · Journal of Community Health · doi:10.1007/s10900-011-9464-5 · Cited by 33
Cardiovascular Disease in Central and East Europe
Pająk, A., & Kozela, M. (2011) · Public health reviews · doi:10.1007/bf03391644 · Cited by 40
García‐García, C., Oliveras, T., Serra, J., Vila, J., Rueda, F., Cediel, G., Labata, C., Ferrer, M., Carrillo, X., Degano, I. R., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.017159 · Cited by 38
Refocusing the Agenda on Cardiovascular Guidelines
Gibbons, G. H., Shurin, S. B., Mensah, G. A., & Lauer, M. S. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.08.003 · Cited by 41
Eapen, Z. J., Liang, L., Shubrook, J. H., Bauman, M. A., Bufalino, V. J., Bhatt, D. L., Peterson, E. D., & Hernandez, A. F. (2014) · American Heart Journal · doi:10.1016/j.ahj.2014.06.007 · Cited by 33
Pavy, B., Barbet, R., Carré, F., Champion, C., Iliou, M., Patrick Jourdain, M., Juillière, Y., Monpère, C., & Brion, R. (2013) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2013.10.002 · Cited by 35
Prevention and Control of Selected Chronic NCDs in Sri Lanka : Policy Options and Action
Engelgau, M. M., Okamoto, K., Navaratne, K. V., & Gopalan, S. S. (2010) · World Bank, Washington, DC eBooks · doi:10.1596/13607 · Cited by 48
Morales, L. S., Flóres, Y. N., Leng, M., Sportiche, N., Gallegos-Carrillo, K., & Salmerón, J. (2014) · Salud Pública de México · doi:10.21149/spm.v56i2.7335 · Cited by 35
Vaughan, A. S., Schieb, L. J., & Casper, M. L. (2020) · PLoS ONE · doi:10.1371/journal.pone.0235839 · Cited by 33
Moving beyond chronological age: frailty as an important risk factor for cardiovascular disease
Orkaby, A. R. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab481 · Cited by 35
Brain health begins with brain care
Singh, S., Gutiérrez-Martínez, L., Newhouse, A. L., Sonni, A., Chemali, Z. N., & Rosand, J. M. (2022) · The Lancet Neurology · doi:10.1016/s1474-4422(22)00397-0 · Cited by 32
Clinician's Guide to the Updated ABCs of Cardiovascular Disease Prevention
Kohli, P., Whelton, S. P., Hsu, S., Yancy, C. W., Stone, N. J., Chrispin, J., Gilotra, N. A., Houston, B. A., Ashen, M. D., Martin, S. S., et al. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.114.001098 · Cited by 34
Latest statistics on cardiovascular disease in A ustralia
Waters, A., Trinh, L., Chau, T., Bourchier, M., & Moon, L. (2013) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12079 · Cited by 32
Use of evidence to support healthy public policy: a policy effectiveness-feasibility loop
Bowman, S., Unwin, N. C., Critchley, J., Capewell, S., Husseini, A. S., Maziak, W., Zaman, S., Romdhane, H. B., Fouad, F. M., Phillimore, P., et al. (2012) · Bulletin of the World Health Organization · doi:10.2471/blt.12.104968 · Cited by 32
Self-citationRezende, L. F. M., Azeredo, C. M., Canella, D. S., Luiz, O. D. C., Levy, R. B., & Eluf‐Neto, J. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.04.176 · Cited by 38
Knowledge about cardiovascular disease in Portugal
Andrade, N., Alves, E., Costa, A. R., Ferreira, P. M., Azevedo, A., & Lunet, N. (2018) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2017.10.017 · Cited by 43
Patterns and predictors of physician adoption of new cardiovascular drugs
Anderson, T. S., Lo‐Ciganic, W., Gellad, W. F., Zhang, R., Huskamp, H. A., Choudhry, N. K., Chang, C. H., Richards‐Shubik, S., Güçlü, H., Jones, B. L., et al. (2017) · Healthcare · doi:10.1016/j.hjdsi.2017.09.004 · Cited by 33
Active leisure, passive leisure and health
Roy, S., & Orazem, P. F. (2021) · Economics & Human Biology · doi:10.1016/j.ehb.2021.101053 · Cited by 34
Hou, X.-Z., Liu, E.-Q., Liu, S., Lv, H., Cui, H.-F., & Han, J. (2023) · Scientific Reports · doi:10.1038/s41598-023-27974-w · Cited by 41
The Concept of the Polypill in the Prevention of Cardiovascular Disease
Wiley, B. M., & Fuster, V. (2014) · Annals of Global Health · doi:10.1016/j.aogh.2013.12.008 · Cited by 33
Ugolini, D., Neri, M., Cesario, A., Marazzi, G., Milazzo, D., Volterrani, M., Bennati, L., Bonassi, S., & Pasqualetti, P. (2012) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2012.08.205 · Cited by 32
Jiang, Z., Sheng, X., Xu, C., Li, W., Chang, X.-X., Sun, L., Yang, X., & Yu, L.-F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075400 · Cited by 32
Low Integrated DNA Repair Score and Lung Cancer Risk
Sevilya, Z., Leitner‐Dagan, Y., Pinchev, M., Kremer, R., Elinger, D., Rennert, H. S., Schechtman, E., Freedman, L. S., Rennert, G., Paz-Elizur, T., et al. (2013) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-13-0318 · Cited by 33
Major Determinants of Serum Homocysteine Concentrations in a Korean Population
Kim, H. J., Kim, M. K., Kim, J. U., Ha, H.-Y., & Choi, B. Y. (2010) · Journal of Korean Medical Science · doi:10.3346/jkms.2010.25.4.509 · Cited by 32
Saving Money or Just Saving Lives? Improving the Productivity of US Health Care Spending
D, K. B. A., Chandra, A., & Skinner, J. (2012) · Annual Review of Economics · doi:10.1146/annurev-economics-080511-110942 · Cited by 32
Cardiac Arrest and Sudden Cardiac Death
Saklani, P., White, J. A., Klein, G. J., & Krahn, A. D. (2013) · Springer eBooks · doi:10.1007/978-1-4471-4441-0_10 · Cited by 32
Lobos, J. M., Royo‐Bordonada, M. Á., Brotons, C., Álvarez-Sala, L., Armario, P., Maiques, A., Mauricio, D., Sans, S., Villar, F., Lizcano‐Álvarez, A., et al. (2009) · PubMed · Cited by 33
Cardiac rehabilitation in skilled nursing facilities: A missed opportunity
Dolansky, M. A., Zullo, M. D., Hassanein, S., Schaefer, J. T., Murray, P., & Boxer, R. (2012) · Heart & Lung · doi:10.1016/j.hrtlng.2011.08.006 · Cited by 31
Trends in Mortality Among Females in the United States, 1900–2010: Progress and Challenges
Hahn, R. A., Chang, M., Parrish, R. G., Teutsch, S. M., & Jones, W. K. (2018) · Preventing Chronic Disease · doi:10.5888/pcd15.170284 · Cited by 35
Christensen, J. J., Arnesen, E., Rundblad, A., Telle‐Hansen, V. H., Narverud, I., Blomhoff, R., Bogsrud, M. P., Retterstøl, K., Ulven, S. M., & Holven, K. B. (2023) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2023.117433 · Cited by 34
Multiple long-term conditions as the next transition in the global diabetes epidemic
Gregg, E. W., Holman, N., Sophiea, M. K., Misra, S., Pearson‐Stuttard, J., Valabhji, J., & Khunti, K. (2025) · Communications Medicine · doi:10.1038/s43856-025-00742-9 · Cited by 35
Preeclampsia and the risk of cardiovascular disease later in life – A review of the evidence
Lee, G., & Tubby, J. (2015) · Midwifery · doi:10.1016/j.midw.2015.09.005 · Cited by 31
Zahnd, G., Orkisz, M., Sérusclat, A., Moulin, P., & Vray, D. (2013) · International Journal of Computer Assisted Radiology and Surgery · doi:10.1007/s11548-013-0945-0 · Cited by 31
Stukel, T. A., Alter, D. A., Schull, M. J., Ko, D. T., & Li, P. (2010) · Medical Care · doi:10.1097/mlr.0b013e3181bd4da7 · Cited by 31
Risk factors for coronary heart disease and survival after myocardial infarction
Nauta, S. T., Deckers, J. W., van der Boon, R. M. A., Akkerhuis, K. M., & van Domburg, R. T. (2012) · European Journal of Preventive Cardiology · doi:10.1177/2047487312460514 · Cited by 38
Beaney, K. E., Cooper, J. A., Shahid, S. U., Ahmed, W., Qamar, R., Drenos, F., Crockard, M. A., & Humphries, S. E. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130754 · Cited by 33
Zou, L., Ma, X., Wu, B., Chen, Y., Xie, D., & Peng, C. (2020) · Free Radical Research · doi:10.1080/10715762.2020.1837793 · Cited by 32
Hoppe, K. K., Smith, M. A., Birstler, J., Kim, K., Sullivan-Vedder, L., LaMantia, J. N., Sinaise, M. R. K., Swenson, M., Fink, J. T., Haggart, R. C., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.55618 · Cited by 36
PET and PET/CT in cardiovascular disease
Gaemperli, O., & Kaufmann, P. A. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06030.x · Cited by 32
Toss, F., Nordström, A., & Nordström, P. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.05.065 · Cited by 31
The Enhancing Secondary Prevention in Coronary Artery Disease trial
McAlister, F. A., Fradette, M., Majumdar, S. R., Williams, R., Graham, M. M., McMeekin, J., Ghali, W. A., Tsuyuki, R. T., Knudtson, M. L., & Grimshaw, J. (2009) · Canadian Medical Association Journal · doi:10.1503/cmaj.090917 · Cited by 33
Distribution of ideal cardiovascular health in a community-based cohort of Middle East population
Moghaddam, M. M., Mohebi, R., Hosseini‐Esfahani, F., Lotfaliany, M., Azizi, F., Saadat, N., & Hadaegh, F. (2014) · Annals of Saudi Medicine · doi:10.5144/0256-4947.2014.134 · Cited by 33
Subgroups of lifestyle patterns among hypertension patients: a latent-class analysis
Ghanbari, J., Mohammadpoorasl, A., Jahangiry, L., Farhangi, M. A., Iranagh, J. A., & Ponnet, K. S. (2018) · BMC Medical Research Methodology · doi:10.1186/s12874-018-0607-6 · Cited by 37
Availability and utilization of cardiovascular fixed-dose combination drugs in the United States
Wang, B., Choudhry, N. K., Gagne, J. J., Landon, J. E., & Kesselheim, A. S. (2015) · American Heart Journal · doi:10.1016/j.ahj.2014.12.014 · Cited by 32
Orozco‐Beltrán, D., Cooper, R., Gil-Guillén, V. F., Bertoméu, V., Pita‐Fernández, S., Durazo-Arvizú, R., Carratalá‐Munuera, C., Cea‐Calvo, L., Bertomeu‐González, V., Seoane‐Pillado, T., et al. (2012) · Revista Española de Cardiología · doi:10.1016/j.recesp.2012.02.026 · Cited by 40
García‐García, C., Sanz, G., Valle, V., Balaguer, L. M., Sala, J., Subirana, I., Martí, H., Marrugat, J., Bruguera, J., Masià, R., et al. (2010) · Revista Española de Cardiología · doi:10.1016/s0300-8932(10)70245-1 · Cited by 30
Gemignani, A. S., Muhlebach, S. G., Abbott, B., Roye, G. D., Harrington, D. T., & Arrighi, J. A. (2011) · Journal of Nuclear Cardiology · doi:10.1007/s12350-011-9405-9 · Cited by 30
Pearson‐Stuttard, J., Bandosz, P., Rehm, C. D., Afshin, A., Peñalvo, J. L., Whitsel, L. P., Danaei, G., Micha, R., Gaziano, T., Lloyd‐Williams, F., et al. (2017) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.116.143925 · Cited by 31
Self-citationEndothelial dysfunction and menopause: is exercise an effective countermeasure?
Witkowski, S., & Serviente, C. F. (2018) · Climacteric · doi:10.1080/13697137.2018.1441822 · Cited by 34
Revascularization in stable coronary disease: evidence and uncertainties
Katritsis, D. G., Mark, D. B., & Gersh, B. J. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0006-z · Cited by 30
Newman, J. D., Alexander, K. P., Gu, X., O’Brien, S. M., Boden, W. E., Govindan, S. C., Senior, R., Moorthy, N., Rezende, P. C., Demkow, M., et al. (2019) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.119.006002 · Cited by 30
Prevalence and management of hypercholesterolemia in France, the Esteban observational study
Blacher, J., Gabet, A., Vallée, A., Ferrières, J., Bruckert, É., Farnier, M., & Olié, V. (2020) · Medicine · doi:10.1097/md.0000000000023445 · Cited by 30
Myocardial Ischemia in the Management of Chronic Coronary Artery Disease: Past and Present
Gibbons, R. J. (2021) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.120.011615 · Cited by 35
Age-Period-Cohort Analysis of Ischemic Heart Disease Morbidity and Mortality in China, 1990–2019
Wei, D., Xiao, W., Zhou, L., Guo, J., Lu, W., & Wang, Y. (2022) · Circulation Journal · doi:10.1253/circj.cj-21-0749 · Cited by 30
Disparities in cardiovascular disease and treatment in the Nordic countries
Højstrup, S., Thomsen, J. H., & Prescott, E. (2023) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2023.100699 · Cited by 39
Gaui, E. N., Klein, C. H., & de Oliveira, G. M. M. (2010) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2010000100010 · Cited by 30
Is the Health Burden Associated With Obesity Changing?
Peeters, A., & Backholer, K. (2012) · American Journal of Epidemiology · doi:10.1093/aje/kws328 · Cited by 33
Stecker, E. C., Teodorescu, C., Reinier, K., Uy‐Evanado, A., Mariani, R., Chugh, H. S., Gunson, K., Jui, J., & Chugh, S. S. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.114.001160 · Cited by 31
Living the Good Life? Mortality and Hospital Utilization Patterns in the Old Order Amish
Mitchell, B. D., Lee, W.-J., Tolea, M. I., Shields, K. S., Ashktorab, Z., Magder, L. S., Ryan, K. A., Pollin, T. I., McArdle, P. F., Shuldiner, A. R., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051560 · Cited by 30
Antiplatelet agents in clinical practice and their haemorrhagic risk.
Gresele, P. (2013) · Europe PMC (PubMed Central) · doi:10.2450/2013.0248-12 · Cited by 30
Myocardial infarction: a paradigm of success in modern medicine
Thiene, G., & Basso, C. (2009) · Cardiovascular Pathology · doi:10.1016/j.carpath.2009.08.002 · Cited by 30
Gender differences in cardiovascular disease prevention
Jackson, G. (2008) · Menopause international · doi:10.1258/mi.2007.007031 · Cited by 30
O'Connor, S. S., Mcclay, M. M., Choudhry, S., Shields, A. D., Carlson, R., Alonso, Y., Lavin, K., Venanzi, L., Comtois, K. A., Wilson, J. E., et al. (2020) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2018.08.001 · Cited by 29
Cherla, A., Kyriopoulos, I., Pearcy, P., Tsangalidou, Z., Hajrulahovic, H., Theodorakis, P. N., Andersson, C., Mehra, M. R., & Mossialos, E. A. (2024) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2024.101079 · Cited by 37
Metadata
- Authors
- Ford, E. S., Ajani, U. A., Croft, J. B., Critchley, J. A., Labarthe, D. R., Kottke, T. E., Giles, W. H., & Capewell, S.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Newcastle University (GB)
- HealthPartners (US)
- University of Liverpool (GB)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2007-06-07
- Volume
- 356
- Issue
- 23
- Pages
- 2388-2398
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2150278133
- Cited by
- 2,757
- References
- 44
- Citations by year
- 2026: 56 · 2025: 66 · 2024: 60 · 2023: 82 · 2022: 100 · 2021: 101 · 2020: 114 · 2019: 129 · 2018: 129 · 2017: 153 · 2016: 163 · 2015: 209 · 2014: 173 · 2013: 198 · 2012: 252
- FWCI
- 127.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Healthcare Systems and Public Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Keywords
- coronary heart disease mortality, mortality decline, cardiovascular risk factors, IMPACT model, secondary prevention after myocardial infarction, revascularization, acute myocardial infarction treatment, unstable angina, heart failure treatment, cholesterol lowering, blood pressure reduction, smoking, physical inactivity, body mass index, diabetes mellitus, sex differences in mortality
- MeSH terms
- Adult, Aged, Aged, 80 and over, Coronary Disease, Female, Humans, Male, Middle Aged, Mortality, Myocardial Infarction, Myocardial Revascularization, Risk Factors, United States
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.